---
figid: PMC10413047__IJMM-52-2-05271-g02
figtitle: CASC9 and lncRNA UCA1 in drug resistance in NSCLC
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10413047
filename: IJMM-52-2-05271-g02.jpg
figlink: /pmc/articles/PMC10413047/figure/F3
number: F3
caption: Mechanisms of CASC9 and lncRNA UCA1 in drug resistance in NSCLC. (A) CASC9
  suppresses the tumor suppressor DUSP1 by recruiting histone methyltransferase EZH2
  and increasing the resistance to gefitinib. (B) LncRNA UCA1 acts as an endogenous
  competitive RNA that can bind with miR-143 to regulate the expression of FOSL2.
  In addition, lncRNA UCA1 increases resistance to cisplatin through the UCA1/miR-495/NRF2
  signaling pathway. CASC9, candidate tumor susceptibility gene 9; lncRNA, long non-coding
  RNA; UCA1, lncRNA urothelial carcinoma-associated; NSCLC, non-small cell lung cancer;
  DUSP1, dual specificity phosphatase 1; miR, microRNA; EZH2, zeste homolog 2
papertitle: Long non-coding RNAs as potential therapeutic targets in non-small cell
  lung cancer (Review)
reftext: Peiyu Tang, et al. Int J Mol Med. 2023 Aug;52(2).
year: '2023'
doi: 10.3892/ijmm.2023.5271
journal_title: International Journal of Molecular Medicine
journal_nlm_ta: Int J Mol Med
publisher_name: D.A. Spandidos
keywords: lncRNA | NSCLC | therapeutic targets | biomarkers | drug resistance
automl_pathway: 0.9400231
figid_alias: PMC10413047__F3
figtype: Figure
redirect_from: /figures/PMC10413047__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10413047__IJMM-52-2-05271-g02.html
  '@type': Dataset
  description: Mechanisms of CASC9 and lncRNA UCA1 in drug resistance in NSCLC. (A)
    CASC9 suppresses the tumor suppressor DUSP1 by recruiting histone methyltransferase
    EZH2 and increasing the resistance to gefitinib. (B) LncRNA UCA1 acts as an endogenous
    competitive RNA that can bind with miR-143 to regulate the expression of FOSL2.
    In addition, lncRNA UCA1 increases resistance to cisplatin through the UCA1/miR-495/NRF2
    signaling pathway. CASC9, candidate tumor susceptibility gene 9; lncRNA, long
    non-coding RNA; UCA1, lncRNA urothelial carcinoma-associated; NSCLC, non-small
    cell lung cancer; DUSP1, dual specificity phosphatase 1; miR, microRNA; EZH2,
    zeste homolog 2
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASC9
  - TMC6
  - SCARNA10
  - UCA1
  - MIR495
  - MIR143
  - FOSL2
  - EZH2
  - DUSP1
  - DUSP12
  - GABPA
  - NFE2L2
---
